This sugar molecule could stop type 1 diabetes, by fooling the immune system

In a fascinating twist, Mayo Clinic researchers discovered that a sugar molecule cancer cells use to hide from the immune system might also protect insulin-producing beta cells in type 1 diabetes. By engineering these cells with the same sugar molecule—sialic acid—they prevented immune attacks in lab models. This approach could lead to better transplant options without broad immune suppression, offering hope for millions living with the autoimmune disease.